Functional advantage after radical segmentectomy versus lobectomy for lung cancer.

PubWeight™: 2.06‹?› | Rank: Top 2%

🔗 View Article (PMID 16305841)

Published in Ann Thorac Surg on December 01, 2005

Authors

Hiroaki Harada1, Morihito Okada, Toshihiko Sakamoto, Hidehito Matsuoka, Noriaki Tsubota

Author Affiliations

1: Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi, Japan.

Articles citing this

Segmentectomy for c-T1N0M0 non-small cell lung cancer. Surg Today (2013) 1.40

Non-intubated video-assisted thoracoscopic surgery anatomical resections: a new perspective for treatment of lung cancer. Ann Transl Med (2015) 1.05

Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma. Ann Cardiothorac Surg (2014) 1.03

Short-term results of thoracoscopic lobectomy and segmentectomy for lung cancer in koo foundation sun yat-sen cancer center. J Thorac Dis (2010) 0.98

Robotic lobectomy and segmentectomy for lung cancer: results and operating technique. J Thorac Dis (2015) 0.91

Surgical management of lung cancer. Semin Intervent Radiol (2013) 0.88

Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy. Diagn Interv Radiol (2014) 0.87

Role of segmentectomy for pulmonary metastases. Ann Cardiothorac Surg (2014) 0.86

Comparison of postoperative pulmonary function and air leakage between pleural closure vs. mesh-cover for intersegmental plane in segmentectomy. J Cardiothorac Surg (2011) 0.84

Combined subsegmentectomy: postoperative pulmonary function compared to multiple segmental resection. J Cardiothorac Surg (2011) 0.84

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases. J Thorac Cardiovasc Surg (2014) 0.84

Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial. Trials (2016) 0.83

Open, thoracoscopic and robotic segmentectomy for lung cancer. Ann Cardiothorac Surg (2014) 0.83

Sublobar resection for early-stage lung cancer. Transl Lung Cancer Res (2014) 0.80

Pulmonary function after lobectomy versus segmentectomy in patients with stage I non-small cell lung cancer. World J Surg (2014) 0.78

Lobectomy vs. segmentectomy for NSCLC (T<2 cm). Ann Cardiothorac Surg (2014) 0.78

Dissection of lung parenchyma using electrocautery is a safe and acceptable method for anatomical sublobar resection. J Cardiothorac Surg (2012) 0.78

Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma. Oncol Rev (2014) 0.77

A segmentectomy of the right upper lobe has an advantage over a right upper lobectomy regarding the preservation of the functional volume of the right middle lobe: analysis by perfusion single-photon emission computed tomography/computed tomography. Surg Today (2010) 0.77

Surgical strategies in the therapy of non-small cell lung cancer. World J Clin Oncol (2014) 0.77

Three-dimensional computed tomography bronchography and angiography in the preoperative evaluation of thoracoscopic segmentectomy and subsegmentectomy. J Thorac Dis (2016) 0.75

Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer? Ann Transl Med (2015) 0.75

Double segmentectomy for T4 lung cancer in a pulmonary-compromised patient. Ann Transl Med (2015) 0.75

Analysis of the variation pattern in right upper pulmonary veins and establishment of simplified vein models for anatomical segmentectomy. Gen Thorac Cardiovasc Surg (2016) 0.75

Minimally invasive VATS left upper lobe apical trisegmentectomy. Ann Cardiothorac Surg (2014) 0.75

Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer. J Cardiothorac Surg (2015) 0.75

Status and Perspectives of Clinical Modes in Surgical Patients With Lung Cancer: A Retrospective Study. Medicine (Baltimore) (2016) 0.75

SBRT in operable early stage lung cancer patients. Transl Lung Cancer Res (2014) 0.75

Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance). Ann Thorac Surg (2016) 0.75

Thoracoscopic superior segmentectomy. Ann Cardiothorac Surg (2014) 0.75

Binocular stereo-navigation for three-dimensional thoracoscopic lung resection. BMC Surg (2015) 0.75

Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis. J Cancer Res Clin Oncol (2017) 0.75

Innovative segmentectomy to remove the posterior segment of the lower lobe (S¹⁰) of the lung. Surg Today (2011) 0.75

Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer? Surg Today (2016) 0.75

Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection. J Cancer Res Clin Oncol (2017) 0.75

Indocyanine green fluorescence-navigated robotic segmentectomy. Surg Endosc (2016) 0.75

Articles by these authors

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med (2004) 6.36

Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg (2006) 3.93

A novel video-assisted anatomic segmentectomy technique: selective segmental inflation via bronchofiberoptic jet followed by cautery cutting. J Thorac Cardiovasc Surg (2007) 3.06

Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. Eur J Cardiothorac Surg (2005) 2.84

Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg (2013) 2.65

Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg (2012) 2.23

Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg (2007) 2.18

A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol (2009) 2.14

Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res (2009) 2.14

Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest (2014) 1.98

Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg (2005) 1.94

Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg (2006) 1.68

Pleomorphic carcinoma of the lung: a surgical outcome. J Thorac Cardiovasc Surg (2007) 1.65

Hybrid surgical approach of video-assisted minithoracotomy for lung cancer: significance of direct visualization on quality of surgery. Chest (2005) 1.62

Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg (2004) 1.61

Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma. Ann Thorac Surg (2013) 1.51

Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg (2002) 1.48

Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg (2011) 1.28

Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg (2004) 1.21

Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg (2004) 1.17

Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci U S A (2006) 1.14

Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer. Cancer Immunol Immunother (2008) 1.10

Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study. Cancer (2010) 1.09

Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis. J Thorac Cardiovasc Surg (2009) 1.06

Division of the pulmonary ligament after upper lobectomy is less effective for the obliteration of dead space than leaving it intact. Surg Today (2004) 1.05

Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung. Jpn J Clin Oncol (2011) 1.04

Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett (2006) 1.03

Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings. J Thorac Cardiovasc Surg (2012) 1.00

Mediastinal angioleiomyoma. Ann Thorac Surg (2002) 0.99

[New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. Gan To Kagaku Ryoho (2009) 0.99

Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg (2005) 0.99

PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest (2004) 0.98

Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma. Lab Invest (2003) 0.98

MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J Exp Clin Cancer Res (2009) 0.98

Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections. J Thorac Cardiovasc Surg (2003) 0.97

NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pac J Cancer Prev (2007) 0.96

Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension. Cancer (2003) 0.94

Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res (2011) 0.94

Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg (2003) 0.94

Advantage of absorbable suture material for pulmonary artery ligation. Gen Thorac Cardiovasc Surg (2010) 0.94

Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery. Surg Today (2011) 0.93

Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg (2004) 0.93

CT fluoroscopy-guided bronchoscopic dye marking for resection of small peripheral pulmonary nodules. Chest (2004) 0.92

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study. Breast Cancer Res Treat (2013) 0.92

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma. J Thorac Cardiovasc Surg (2013) 0.92

Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case. Surg Today (2012) 0.91

Empyema necessitatis into the retroperitoneal space. Ann Thorac Surg (2002) 0.90

Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg (2003) 0.90

Cloning of a soluble isoform of the SgIGSF adhesion molecule that binds the extracellular domain of the membrane-bound isoform. Oncogene (2004) 0.90

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer. Breast Cancer Res Treat (2015) 0.89

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer. Breast (2013) 0.88

Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema. Thorax (2013) 0.87

Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis. Surg Today (2010) 0.87

Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Ann Thorac Surg (2004) 0.87

Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. Oncol Rep (2008) 0.86

Interferon (alpha, beta and omega) receptor 2 is a prognostic biomarker for lung cancer. Pathobiology (2012) 0.85

Technical feasibility and cosmetic advantage of hybrid endoscopy-assisted breast-conserving surgery for breast cancer patients. J Laparoendosc Adv Surg Tech A (2012) 0.85

Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non-small cell lung cancer. Cancer (2013) 0.85

Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer. Int J Oncol (2009) 0.85

Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. Invest Ophthalmol Vis Sci (2002) 0.84

Laparoscopic thoracic duct clipping for persistent chylothorax after extrapleural pneumonectomy. Ann Thorac Surg (2012) 0.84

Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition. Cancer Sci (2013) 0.83

A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma. Jpn J Clin Oncol (2009) 0.83

Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer. Int J Cancer (2011) 0.83

Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells. Int J Cancer (2010) 0.83

Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation. J Thorac Cardiovasc Surg (2005) 0.83

Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma. Cancer (2007) 0.82

Initial results of robot-assisted thoracoscopic surgery in Japan. Gen Thorac Cardiovasc Surg (2014) 0.82

APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. Asian Pac J Cancer Prev (2010) 0.82

Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report. BMC Gastroenterol (2012) 0.82

Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer (2003) 0.82

Airway stenting for malignant respiratory complications in esophageal cancer. Anticancer Res (2012) 0.82